SCHEMBL5680671

SCHEMBL5680671

CCCCc1cc(CC)c(C)c(O)c1OC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 6/20 0.38
TYR P14679 2/20 0.36
PTGES O14684 2/20 0.35
TOP2A P11388 1/20 0.35
PTPN1 P18031 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35
GABRE P78334 1/20 0.35
GABRA6 Q16445 1/20 0.35
GABRG1 Q8N1C3 1/20 0.35
GABRG3 Q99928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5676927 0.96 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5678220 0.94 TYR (0.36) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5678150 0.93 ALOX5 (0.37) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5680555 0.93 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5676682 0.85 MAOA (0.40) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5920566 0.84 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5677895 0.84 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5680436 0.84 ALOX5 (0.37) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5678562 0.84 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1
SCHEMBL5921127 0.84 ALOX5 (0.43) ALOX5TYRPTGESTOP2APTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR ALOX5 833/4885TYR 275/4885PTGES 525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.